1. Home
  2. PRCT vs UTG Comparison

PRCT vs UTG Comparison

Compare PRCT & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • UTG
  • Stock Information
  • Founded
  • PRCT 2009
  • UTG 2003
  • Country
  • PRCT United States
  • UTG United States
  • Employees
  • PRCT N/A
  • UTG N/A
  • Industry
  • PRCT Medical Specialities
  • UTG Investment Managers
  • Sector
  • PRCT Health Care
  • UTG Finance
  • Exchange
  • PRCT Nasdaq
  • UTG Nasdaq
  • Market Cap
  • PRCT 2.9B
  • UTG 2.8B
  • IPO Year
  • PRCT 2021
  • UTG N/A
  • Fundamental
  • Price
  • PRCT $53.03
  • UTG $31.57
  • Analyst Decision
  • PRCT Strong Buy
  • UTG
  • Analyst Count
  • PRCT 7
  • UTG 0
  • Target Price
  • PRCT $91.43
  • UTG N/A
  • AVG Volume (30 Days)
  • PRCT 1.0M
  • UTG 317.8K
  • Earning Date
  • PRCT 04-24-2025
  • UTG 01-01-0001
  • Dividend Yield
  • PRCT N/A
  • UTG 7.28%
  • EPS Growth
  • PRCT N/A
  • UTG N/A
  • EPS
  • PRCT N/A
  • UTG 9.86
  • Revenue
  • PRCT $224,498,000.00
  • UTG $96,107,593.00
  • Revenue This Year
  • PRCT $46.28
  • UTG N/A
  • Revenue Next Year
  • PRCT $32.67
  • UTG N/A
  • P/E Ratio
  • PRCT N/A
  • UTG $3.20
  • Revenue Growth
  • PRCT 64.84
  • UTG 8.35
  • 52 Week Low
  • PRCT $47.04
  • UTG $25.26
  • 52 Week High
  • PRCT $103.81
  • UTG $35.29
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 42.69
  • UTG 50.46
  • Support Level
  • PRCT $51.27
  • UTG $28.40
  • Resistance Level
  • PRCT $54.75
  • UTG $31.84
  • Average True Range (ATR)
  • PRCT 3.64
  • UTG 1.12
  • MACD
  • PRCT 0.19
  • UTG 0.10
  • Stochastic Oscillator
  • PRCT 49.48
  • UTG 71.91

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About UTG Reaves Utility Income Fund of Beneficial Interest

Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.

Share on Social Networks: